Acute Myeloid Leukemia (AML)

• Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell … Pending
  2024-520326-11-00 4
• A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting
  2024-512753-24-00 5 2025-08-05
• A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML … Recruiting
  2024-512733-32-00 5 2025-03-31
• A phase 1/2 multicenter open-label study to investigate treatment of hydroxyurea (HU) in combination with valproic acid (VPA) or 6- mercapto … Recruiting
  2022-501992-15-00 9 2024-05-21
• Phase II study of (early) combination salvage therapy with Venetoclax and intensified Decitabine in Relapsed/Refractory AML Recruiting
  2022-502665-15-00 4 2023-10-26
• Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies Recruiting
  2022-501797-19-00 1 2023-07-13
• A study of MP0533 in patients with blood cancer. Recruiting
  2023-505259-39-00 7 2023-03-02
• PENTALLO (PENTAglobin in Acute Leukemia and ALLOgeneic transplants) Recruitment ended
  2024-518940-19-02 4 2025-01-28
• A Study of the Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination with Venetoclax in AML Recruitment ended
  2024-516294-78-00 4 2022-06-17
• HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Recruitment ended
  2022-502478-18-00 4 2019-12-20
• A clinical trial to evaluate the safety and effectiveness of a combination of either AG-12or AG-221 tablets with azacitidine injections in p … Recruitment ended
  2024-511722-31-00 9 2016-11-29
• Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM Ended
  2024-517381-42-00 1 2024-10-14
• VEN-DEC GITMO Study Ended
  2024-518792-54-00 4 2021-05-13
• Phase I/II trial of S65487 plus azacitidine in acute myeloid leukemia Ended
  2023-510051-27-00 7 2021-02-25
• Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies Ended
  2024-515827-12-00 1 2020-01-28
• A study to see how safe and effective the drug Luveltamab Tazevibulin (STRO-002) is in treating infants and children under 12 years old with … Ended
  2023-506240-16-00 9

Showing 1–16 of 16 trials